Armin Rath

Company: Cytovia Therapeutics

Job title: Head of New Product Development & Research Alliances

Seminars:

Roundtable Discussion: To Auto or to Allo? Evaluating the Future of iPSC-Derived Cell Therapies to Inform Our Next Steps 10:00 am

Considering the practicalities of a scaled-up autonomous approach to re-evaluate its clinical acceptance Understanding the transection between autologous and allogeneic translational approaches to promote a holistic iPSC strategy Identifying how industry, service providers and academia can collaborate to support the advancement of iPSCs to the clinicRead more

day: Conference Day One